Biotecnol is working in the field of cancer immunotherapy using proprietary antibody-based technologies to engineer and develop therapeutic products which utilize a patient’s own immune system to fight cancer. These powerful approaches are based on T-Cells and NK-Cell activation and on modulation strategies of key immune checkpoint regulators.